Nippon India Pharma Fund vs HDFC Pharma and Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹1786 Cr | ₹8569 Cr |
Min Investment | ₹100 | ₹5000 |
Min SIP Invesment | ₹100 | ₹500 |
Min Addl Investment | ₹100 | ₹1000 |
Launch Date | 04 Oct 2023 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare Index | BSE Healthcare |
Turn Over | % | 21% |
Expense Ratio | 2.14 | 1.82 |
Manager | Dhruv Muchhal | Sailesh Raj Bhan |
ISIN Code | INF179KC1HL7 | INF204K01968 |
Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | 5.23% | 2.59% |
6 Month | 11.49% | 10.5% |
1 Year | 20.74% | 8.47% |
3 Year | - | 24.46% |
5 Year | - | 20.23% |
SIP Return Analysis
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | 10.88% | 7.77% |
1 Year | 22.46% | 12.61% |
3 Year | - | 25.2% |
5 Year | - | 20.43% |
Rolling Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 29.56% | 17.31% |
3 Year | - | 20.52% |
5 Year | - | 20.64% |
Risk Management
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | - | 14.75% |
Sharp | - | 1.20% |
Beta | - | 0.90% |
Alpha | - | 0.72% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Dhruv Muchhal | Sailesh Raj Bhan |
Total AUM | ₹520687 Cr | ₹96086 Cr |
Funds Managed | 40 | 5 |
HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 6.79 | 0.53 |
Large Cap | 32.43 | 35.06 |
Mid Cap | 25.43 | 31.99 |
Small Cap | 35.35 | 32.41 |
Sector Allocation
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 3.18 | 0.53 |
Basic Materials | 2.04 | - |
Healthcare | 94.78 | 99.47 |
Top Comparisons
Axis Aggressive Hybrid Fund - Regular Plan - Growth Option
3Y Returns11.08%
HSBC Aggressive Hybrid Fund - Regular Growth
3Y Returns15.86%
SBI Flexicap Fund - REGULAR PLAN -Growth Option
3Y Returns13.24%
360 ONE FlexiCap Fund Regular - Growth
3Y Returns0%
BANDHAN INNOVATION FUND REGULAR PLAN GROWTH
3Y Returns0%
Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Regular Plan - Growth
3Y Returns21.81%
PGIM India Dynamic Bond Fund - Growth Option
3Y Returns7%
Canara Robeco Dynamic Bond Fund - Regular Plan - Growth Option
3Y Returns6.37%